Replies to post #404054 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I was just hinting the misogyny in my previous post and then took it out. Exactly why you can’t see what she is doing. And her Sale Leaseback deal was not hers either?

These are standard tactics and she is a highly intelligent woman. They were discussing this kind of dealing to bootstrap small bios in regard to NWBO a few years back and certain interests spun it into all manner of nonsense, referencing Enron. Total BS smear campaign which you guys appear to have swallowed hook, line and sinker and keep repeating in various forms, as you just did in the previous post.

[sentiment_stocks]

I believe LP has been invested in the development of cellular therapeutics for quite some time.

While Cognate's headquarters had been in Maryland, they originally operated a GMP facility out of Sunnyvale in California.

Cognate BioServices, Inc. is a fully integrated contract bioservices organization providing the highest level of scientific and management expertise to its clients who are focused on the commercialization of cell- based products. Its comprehensive service package supports new and developing companies in the specific areas of preclinical research, assay development, regulatory services, process development, cGMP cell-based manufacturing, environmental health & safety, and laboratory support services. In addition to the corporate headquarters in Baltimore, Maryland, Cognate BioServices operates a GMP manufacturing facility in Sunnyvale, California. For more information visit the company's website at www.cognatebioservices.com.
https://www.biospace.com/article/releases/cognate-therapeutics-inc-changes-name-to-cognate-bioservices-inc-/

I can't remember which company had initially built the Memphis building (I think it was a failed pharma company), however, whoever it was then sold it to Cognate, and they moved the manufacturing there from Sunnyvale.

Her Toucan Capital has certainly been around for quite some time. This article, initially dated in 2001, discusses how some of the funds were gathered to invest in earl stage investments.
https://www.bizjournals.com/oldmht/stories/2001/01/29/story51.html

Then in 2006, the ED of the Maryland Technology Development Corp, leaves that company to join Toucan with the article stating, "Singerman called Toucan Capital the most effective early-stage private fund he'd worked with in more than two decades of economic development work. "There was a real fit between what they were doing and my experience," Singerman said in an interview.
https://www.bizjournals.com/baltimore/stories/2006/01/16/daily16.html